Delivery Order SPE2DB24D2205-SPE2DB24FDUZX

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This Delivery Order contract, valued at $3,613.72, has a firm fixed price and an ultimate completion date of May 15, 2024. The contract is not set aside for any special designation. Amerisourcebergen Drug...
This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a major supplier of medical products and services to the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, and has a ceiling value of $2,952.43. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of 100 capsules of the pharmaceutical product Vyvanse 40mg to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office Division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $5,909.10 and is a firm fixed-price delivery order. It was awarded on...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of 4,565,005,875 units of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,293.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division on June 26, 2024, with an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,564.56. The contract has an ultimate completion date of July 9, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Vyvanse 60 mg capsules to the Defense Logistics Agency (DLA). The $2,202.34 firm fixed-price delivery order was awarded on October 23, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a firm fixed price, ceiling value of $1,121.72, and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Vyvanse 40 mg capsules (100-count bottles) to the Defense Logistics Agency (DLA), a defense agency. The $1,337.70 firm-fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDUZX
    Delivery Order

This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,743.20. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 5, 2024.

Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The company has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/3/24, 12:14 PM